- Home
- BDTX vs ZYBT Comparison
BDTX vs ZYBT Comparison
Compare BDTX & ZYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- ZYBT
- Stock Information
- Founded
- BDTX 2014
- ZYBT 2004
- Country
- BDTX United States
- ZYBT China
- Employees
- BDTX N/A
- ZYBT N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- ZYBT
- Sector
- BDTX Health Care
- ZYBT
- Exchange
- BDTX Nasdaq
- ZYBT NYSE
- Market Cap
- BDTX 132.5M
- ZYBT 340.3M
- IPO Year
- BDTX 2020
- ZYBT 2025
- Fundamental
- Price
- BDTX $2.60
- ZYBT $5.92
- Analyst Decision
- BDTX Strong Buy
- ZYBT
- Analyst Count
- BDTX 6
- ZYBT 0
- Target Price
- BDTX $14.83
- ZYBT N/A
- AVG Volume (30 Days)
- BDTX 1.3M
- ZYBT 367.2K
- Earning Date
- BDTX 08-05-2025
- ZYBT 01-01-0001
- Dividend Yield
- BDTX N/A
- ZYBT N/A
- EPS Growth
- BDTX N/A
- ZYBT N/A
- EPS
- BDTX 0.09
- ZYBT 0.06
- Revenue
- BDTX $70,000,000.00
- ZYBT $26,111,272.00
- Revenue This Year
- BDTX N/A
- ZYBT N/A
- Revenue Next Year
- BDTX N/A
- ZYBT N/A
- P/E Ratio
- BDTX $28.15
- ZYBT $100.93
- Revenue Growth
- BDTX N/A
- ZYBT N/A
- 52 Week Low
- BDTX $1.20
- ZYBT $3.50
- 52 Week High
- BDTX $6.75
- ZYBT $14.30
- Technical
- Relative Strength Index (RSI)
- BDTX 61.72
- ZYBT N/A
- Support Level
- BDTX $2.34
- ZYBT N/A
- Resistance Level
- BDTX $2.71
- ZYBT N/A
- Average True Range (ATR)
- BDTX 0.18
- ZYBT 0.00
- MACD
- BDTX -0.01
- ZYBT 0.00
- Stochastic Oscillator
- BDTX 79.65
- ZYBT 0.00
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About ZYBT ZHENGYE BIOTECHNOLOGY HLDG LTD
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.